Spotlight -

Downstream Processing|

Upstream Processing

Development

Latest News

February 15th 2004

Qualifying Network Infrastructure - A Risk-Based Approach

By Ludwig Huber

Networks are part of the compliance picture. Recent FDA warning letters show the agency considers network monitoring and qualification a necessary part of maintaining the security and integrity of electronic records.

October 1st 2003

Validation of Commercial-Off-the-Shelf Calibration Management Systems: Managing Instruments Cost-Effectively

By Jim Erickson

August 1st 2003

Large-Scale Manufacturing of Plasmid DNA for Gene Therapy and DNA Vaccination -- Part 1: The Suitability of Current Techniques to Purify Plasmid Without Adding RNase

By Alex Eon-Duval

Research into Cold Cancers Heating Up

Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Research into Cold Cancers Heating Up

Proprietary Cell-Line Development for High-Titer AAV Manufacturing

Proprietary cell lines offer opportunities for achieving high AAV titers.

Proprietary Cell-Line Development for High-Titer AAV Manufacturing

Bracing for a Future Wave of Advanced Therapies

In the ATMP space, CGTs are hitting their stride with unprecedented approvals in the past year alone.

Bracing for a Future Wave of Advanced Therapies

Trending on BioPharm International

Analytics, Automation, and Quality Driving the Next Era of Drug Development

Therapeutic Nucleic Acids: Advanced Solutions for Downstream Processing & Analysis

Rentschler’s Time Capsule and How it Symbolizes European Biotech Progress

© 2025 MJH Life Sciences^®

All rights reserved.